Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study

Jaskaran S. Kang, Maria C. Bennell, Feng Qiu, Merril L. Knudtson, Peter C. Austin, Dennis T. Ko and Harindra C. Wijeysundera
August 08, 2016 4 (3) E409-E416; DOI: https://doi.org/10.9778/cmajo.20150138
Jaskaran S. Kang
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria C. Bennell
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Qiu
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merril L. Knudtson
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Austin
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis T. Ko
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MDMSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harindra C. Wijeysundera
Division of Cardiology (Kang, Bennell, Ko, Wijeysundera), Sunnybrook Health Sciences Centre, Schulich Heart Centre, University of Toronto; Institute for Clinical Evaluative Sciences (Qiu, Austin, Ko, Wijeysundera), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Knudtson), University of Calgary, Calgary, Alta.; Institute of Health Policy, Management and Evaluation (Austin, Ko, Wijeysundera), University of Toronto, Toronto, Ont.
MDPhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Selection of patients for the study. Note: CABG = coronary artery bypass grafting, MI = myocardial infarction, PCI = percutaneous coronary intervention.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Variation in individual- and hospital-level costs. The median is plotted for each centre as a horizontal line, the boxes represent the interquartile range, and the circles represent the mean.

Tables

  • Figures
    • View popup
    Table 1: Baseline characteristics of patients with stable angina, by initial treatment strategy Table 1: Baseline characteristics of patients with stable angina, by initial treatment strategy
    Variable% of patients*p value
    (medical therapy v. revascularization)
    % of patients*
    Total
    n = 39 126
    Medical therapy
    n = 15 138
    Revascularization
    n = 23 988
    PCI
    n = 15 601
    CABG
    n = 8387
    Patient-level factors
    Demographics
    Age, mean ± SD, yr66.0 ± 10.367.0 ± 10.265.3 ± 10.3< 0.00165.0 ± 10.766.0 ± 9.7
    Sex, male 75.374.375.9< 0.00172.981.3
    Rural residence14.514.414.50.714.614.5
    Income quintile< 0.001
       1 (lowest)18.619.617.918.417.1
       220.420.420.420.420.6
       320.220.320.220.319.9
       420.720.221.020.821.3
       5 (highest)20.119.420.520.221.1
    Medical comorbidities
    PVD9.411.58.1< 0.0017.69.0
    Previous MI28.135.823.3< 0.00124.820.4
    COPD6.98.65.8< 0.0016.15.1
    Charlson Comorbidity Index score, mean ± SD0.9 ± 1.31.1 ± 1.50.8 ± 1.2< 0.0010.7 ± 1.30.8 ± 1.2
    Cardiac risk factors
    Diabetes44.048.041.4< 0.00140.543.1
    Hypertension86.789.584.9< 0.00184.985.1
    Hyperlipidemia80.883.079.5< 0.00179.978.7
    History of smoking 31.633.230.5< 0.00130.331.0
    Cardiac status/testing
    Native stenosis†
       LM13.010.814.4< 0.0015.531.0
       Proximal LAD33.228.736.0< 0.00129.747.6
       Mid/distal LAD49.647.551.0< 0.00146.060.3
       Circumflex51.550.951.90.0743.667.2
       RCA60.860.560.90.454.772.6
    Had previous CABG< 0.001
       Yes18.030.110.415.11.6
       No81.969.989.584.998.2
    LV function< 0.001
       ≤ 34%5.48.43.53.34.0
       35%-49%12.916.011.010.611.7
       ≥ 50%48.646.550.049.750.5
       NA33.029.135.536.433.8
    Exercise ECG risk< 0.001
       High risk27.721.331.728.837.1
       Low risk22.422.922.223.020.7
       Uninterpretable4.94.84.95.34.2
       NA45.051.141.242.938.0
    Patient-level factors cont'd
    Cardiac status/testing cont'd
    Functional imaging risk< 0.001
       High risk32.031.232.631.135.3
       Low risk23.025.121.723.219.1
       Unknown/NA44.943.745.745.745.7
    CCS class< 0.001
    016.522.013.011.316.2
    114.015.912.812.313.8
    238.335.540.040.838.5
    328.524.231.132.329.0
    42.82.43.03.32.5
    Physician-level factors
    Referral physician0.01
    Family physician25.726.125.525.625.3
    Cardiology41.440.514.942.141.6
    Internal medicine9.49.39.69.110.4
    Other6.66.86.56.27.0
    Missing16.917.416.517.015.6
    Hospital-level factors
    Annual no. of catheterization procedures, mean ± SD4092.3 ± 1696.44031.3 ± 1684.34130.9 ± 1702.9< 0.0014120.9 ± 1702.64149.5 ± 1703.6
    Hospital type< 0.001
       Catheterization only13.213.613.013.412.2
       PCI and    catheterization only6.17.25.45.06.1
       CABG, PCI and    catheterization80.879.381.781.781.8

    CABG = coronary artery bypass grafting, Cath = catheterization, CCS = Canadian Cardiovascular Society, COPD = chronic obstructive pulmonary disease, ECG = electrocardiogram, LAD = left anterior descending, LM = left main, LV = left ventricular, MI = myocardial infarction, NA = not done, PCI = percutaneous coronary intervention, PVD = peripheral vascular disease, RCA = right coronary artery.

    *Unless stated otherwise.

    †LM if ≥ 50% stenosis, proximal LAD if ≥ 70% stenosis, mid/distal LAD if ≥ 70% stenosis, circumflex if ≥ 70% stenosis, RCA if ≥ 70% stenosis.

      • View popup
      Table 2: Components of 1-year mean costs
      CategoryCost, $p value
      (medical therapy v. revascularization)
      Cost, $
      TotalMedicalRevascularizationCABGPCI
      Acute care hospital admission11 373703814 109< 0.00125 9277755
      Emergency department3723673750.3403361
      Surgery269120903071< 0.00119013699
      Physician visits544940796313< 0.00110 0864284
      Medication*1810185717800.00414761944
      Laboratory1941951930.3217180
      Long-term care549329< 0.0014719

      Note: CABG = coronary artery bypass grafting, PCI = percutaneous coronary intervention.

      *For patients > 65 years of age.

        • View popup
        Table 3: Predictors of 1-year cumulative health care costs Table 3: Predictors of 1-year cumulative health care costs
        CovariateCost ratio (95% CI)
        Treatment*
        Medical managementReference
        PCI1.27 (1.24-1.31)
        CABG2.62 (2.53-2.71)
        Patient-level factors
        Demographic characteristics
        Age, yr1.01 (1.01-1.01)
        Sex, male0.96 (0.95-0.98)
        Rural residence0.97 (0.95-0.99)
        Income quintile
           5 (highest)Reference
           1 (lowest)1.10 (1.07-1.12)
           21.04 (1.02-1.07)
           31.02 (1.00-1.05)
           41.02 (1.00-1.05)
        Medical comorbidities
        Peripheral vascular disease1.25 (1.21-1.28)
        Previous MI0.95 (0.93-0.97)
        COPD1.10 (1.07-1.13)
        Charlson score1.17 (1.16-1.17)
        Cardiac risk factors
        Diabetes1.00 (0.99-1.02)
        Hypertension1.11 (1.08-1.13)
        Hyperlipidemia0.95 (0.93-0.97)
        History of smoking1.00 (0.99-1.02)
        Cardiac status/testing
        Native stenosis†
           LM1.12 (1.09-1.15)
           Proximal LAD1.10 (1.08-1.11)
           Mid/distal LAD1.08 (1.06-1.09)
           Circumflex1.11 (1.09-1.12)
           RCA1.09 (1.07-1.11)
        Previous CABG0.83 (0.82-0.85)
        LV function, %
           ≥ 50Reference
           35-491.03 (1.00-1.05)
           ≤ 341.14 (1.10-1.18)
           NA0.95 (0.93-0.97)
        Patient-level factors cont'd
        Cardiac status/testing cont'd
        Exercise ECG risk
           Low riskReference
           High risk1.04 (1.02-1.06)
           Uninterpretable1.09 (1.05-1.14)
           NA1.24 (1.21-1.27)
        Functional imaging risk
           Low riskReference
           High risk1.01 (0.99-1.03)
           Unknown/NA1.05 (1.03-1.08)
        CCS class
           0Reference
           10.90 (0.87-0.92)
           20.88 (0.85-0.90)
           30.90 (0.88-0.92)
           40.86 (0.82-0.90)
        Physician factors
        Referral physician
        Family physicianReference
        Cardiology1.02 (1.01-1.05)
        Internal medicine1.00 (0.98-1.03)
        Other1.22 (1.19-1.27)
        Missing1.03 (1.00-1.05)
        Hospital factors
        Hospital revascularization ratio*
        LowReference
        Medium1.03 (0.93-1.15)
        High1.08 (0.97-1.21)
        Annual catheterization volume0.99 (0.99-0.99)

        Note: CABG = coronary artery bypass grafting, CI = confidence interval, COPD = chronic obstructive pulmonary disease, ECG = electrocardiography, LAD = left anterior descending, LM = left main, LV = left ventricular, MI = myocardial infarction, NA = not done or missing, PCI = percutaneous coronary intervention, RCA = right coronary artery.

        *The 2 main covariates of interest: treatment type and hospital revascularization ratio.

        †LM if ≥ 50% stenosis, proximal LAD if ≥ 70% stenosis, mid/distal LAD if ≥ 70% stenosis, circumflex if ≥ 70% stenosis, RCA if ≥ 70% stenosis.

        PreviousNext
        Back to top

        In this issue

        CMAJ Open: 4 (3)
        Vol. 4, Issue 3
        4 Aug 2016
        • Table of Contents
        • Index by author

        Article tools

        Respond to this article
        Print
        Download PDF
        Article Alerts
        To sign up for email alerts or to access your current email alerts, enter your email address below:
        Email Article

        Thank you for your interest in spreading the word on CMAJ Open.

        NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

        Enter multiple addresses on separate lines or separate them with commas.
        Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study
        (Your Name) has sent you a message from CMAJ Open
        (Your Name) thought you would like to see the CMAJ Open web site.
        CAPTCHA
        This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
        Citation Tools
        Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study
        Jaskaran S. Kang, Maria C. Bennell, Feng Qiu, Merril L. Knudtson, Peter C. Austin, Dennis T. Ko, Harindra C. Wijeysundera
        Aug 2016, 4 (3) E409-E416; DOI: 10.9778/cmajo.20150138

        Citation Manager Formats

        • BibTeX
        • Bookends
        • EasyBib
        • EndNote (tagged)
        • EndNote 8 (xml)
        • Medlars
        • Mendeley
        • Papers
        • RefWorks Tagged
        • Ref Manager
        • RIS
        • Zotero
        Share
        Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study
        Jaskaran S. Kang, Maria C. Bennell, Feng Qiu, Merril L. Knudtson, Peter C. Austin, Dennis T. Ko, Harindra C. Wijeysundera
        Aug 2016, 4 (3) E409-E416; DOI: 10.9778/cmajo.20150138
        Twitter logo Facebook logo Mendeley logo
        • Tweet Widget
        • Facebook Like

        Related Articles

        • PubMed
        • Google Scholar

        Cited By...

        • No citing articles found.
        • Google Scholar

        Similar Articles

        Collections

        • Nonclinical
          • Health Economics - see also Medicare
        • Clinical
          • Cardiovascular Medicine
            • Other cardiovascular medicine

        Content

        • Current issue
        • Past issues
        • Collections

        About

        • General Information
        • Staff
        • Editorial Board
        • Advisory Panel
        • Contact Us
        • Reprints
        • Copyright and Permissions
        CMAJ Group

        Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

        All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

        To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

        CMA Civility, Accessibility, Privacy

         

         

        Powered by HighWire